Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata treatment varies, with no optimal method established yet.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

AGA can occur in children with family history; early diagnosis and treatment important.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

FFA's causes may include environmental triggers and genetic factors.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

PRP more effective than minoxidil 5% for treating alopecia areata.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Vitamin D receptor is crucial for starting hair growth after birth.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.